Helpful Links
Novartis settles patent litigation on Gleevec® (imatinib mesylate) with Sun Pharma subsidiary
Teva Announces Launch of Generic Gleevec® Tablets in the United States
US Food and Drug Administration
FDA Orange Book
European Medicines Agency
Health Canada Patent Register
Drug Cost Look-Up
Other Resources:
http://www.bpac.org.nz/magazine/2009/generics/docs/bpjse_generics_bio_pages_4-8.pdf
https://www.ftc.gov/sites/default/files/documents/reports/authorized-generic-drugs-short-term-effects-and-long-term-impact-report-federal-trade-commission/authorized-generic-drugs-short-term-effects-and-long-term-impact-report-federal-trade-commission.pdf
https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104c17.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598066/
http://www.bloodjournal.org/content/121/22/4439?sso-checked=true